These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25347175)

  • 41. Eligibility for treatment with omalizumab in Italy and Germany.
    Buhl R; Marco AG; Cohen D; Canonica GW
    Respir Med; 2014 Jan; 108(1):50-6. PubMed ID: 24315468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Asthma in pregnancy.
    Dombrowski MP; Schatz M
    Clin Obstet Gynecol; 2010 Jun; 53(2):301-10. PubMed ID: 20436305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An update on paediatric asthma.
    Hedlin G; Konradsen J; Bush A
    Eur Respir Rev; 2012 Sep; 21(125):175-85. PubMed ID: 22941882
    [No Abstract]   [Full Text] [Related]  

  • 44. Many asthma patients experience persistent symptoms despite appropriate clinical and guideline-based treatment with inhaled corticosteroids.
    Mogil J
    J Am Acad Nurse Pract; 2007 Sep; 19(9):459-70. PubMed ID: 17760570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managing patients with chronic severe asthma: rise to the challenge.
    Polosa R; Benfatto GT
    Eur J Intern Med; 2009 Mar; 20(2):114-24. PubMed ID: 19327598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
    Taramarcaz P; Hauser C; Rochat T
    Rev Med Suisse; 2007 Apr; 3(108):1050-2, 1054-5. PubMed ID: 17552257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of severe asthma: targeting the airways, comorbidities and risk factors.
    Gibson PG; McDonald VM
    Intern Med J; 2017 Jun; 47(6):623-631. PubMed ID: 28580744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years.
    Walker S; Burch J; McKenna C; Wright K; Griffin S; Woolacott N
    Health Technol Assess; 2011 May; 15 Suppl 1():13-21. PubMed ID: 21609649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacologic therapy of bronchial asthma].
    Herjavecz I
    Orv Hetil; 2003 Aug; 144(33):1639-40. PubMed ID: 14564926
    [No Abstract]   [Full Text] [Related]  

  • 50. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Severe Asthma].
    Hagmeyer L; Randerath WJ
    Dtsch Med Wochenschr; 2015 Oct; 140(20):1524-8. PubMed ID: 26445257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-adherence in difficult asthma and advances in detection.
    Lindsay JT; Heaney LG
    Expert Rev Respir Med; 2013 Dec; 7(6):607-14. PubMed ID: 24164107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk factors of frequent exacerbations in difficult-to-treat asthma.
    Butler C; Heaney LG
    Eur Respir J; 2006 Jun; 27(6):1324-5; author reply 1325-6. PubMed ID: 16772398
    [No Abstract]   [Full Text] [Related]  

  • 54. Severe Asthma in Primary Care: Identification and Management.
    Trevor JL; Chipps BE
    Am J Med; 2018 May; 131(5):484-491. PubMed ID: 29355509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Managing asthma: an evidence-based approach to optimizing inhaled corticosteroid treatment.
    Fromer L
    South Med J; 2010 Oct; 103(10):1038-44. PubMed ID: 20818314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of a medication-based asthma index for population research.
    Ungar WJ; Chapman KR; Santos MT
    Am J Respir Crit Care Med; 2002 Jan; 165(2):190-4. PubMed ID: 11790653
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WHO universal definition of severe asthma.
    Bush A; Zar HJ
    Curr Opin Allergy Clin Immunol; 2011 Apr; 11(2):115-21. PubMed ID: 21301329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of discussing exercise test results of young asthmatic children on adherence to maintenance medication.
    Visser R; Brusse-Keizer M; van der Palen J; Klok T; Thio BJ
    J Asthma; 2015 Sep; 52(7):743-8. PubMed ID: 25982906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mepolizumab (Nucala) for severe eosinophilic asthma.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):11-2. PubMed ID: 26761344
    [No Abstract]   [Full Text] [Related]  

  • 60. The adolescent with asthma: fostering adherence to optimize therapy.
    Jones BL; Kelly KJ
    Clin Pharmacol Ther; 2008 Dec; 84(6):749-53. PubMed ID: 18946465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.